explore -WSS

explore

author：comprehensive 2025-09-30 20:47:29 - browse：6372

Home health and hospice chain Amedisys has chosen a new corporate owner.

Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Erich Jarvis studies song birds to learn about human stuttering

WSS

Readout Newsletter: Merck, Vertex, and Viking updates

Feng Zhang suggests Editas didn’t move quickly enough to find product targets

Bring on the sabbaticals for nurses

Chinese researcher claims birth of first gene

U.K. officials, researchers try to ease path for bespoke genetic treatments

Texas board proposes rules on abortion law emergency exemption

knowledge

explore

knowledge

How one medical school became remarkably diverse

Patient advocates debate FDA's accelerated approval process

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

FDA's naming rule on biosimilars has undermined competition

Peter Hotez and the public health issue of online harassment

Biotech investment managers search for lucrative opportunities

Jerome Adams on the need for new antivirals for Covid

What Kate Middleton's cancer revelation might teach the world

Apple is now the first public company to be valued at $3 trillion

Yancopoulos of Regeneron works to expand Dupixent success

hotspot

Texas board proposes rules on abortion law emergency exemption

Yancopoulos of Regeneron works to expand Dupixent success

CRISPR technology availability, affordability needs to be expanded

Covid vaccine financial winners and losers, from Pfizer to Novavax

Food as medicine: Medically tailored meals may get standardized

Readout Newsletter: Merck, Vertex, and Viking updates

focus

Wikipedia

entertainment

entertainment